Table 1.
Baseline characteristics of ovarian cancer death in Pudong, Shanghai, China from 2005 to 2020.
| Characteristic | Deaths (n, %) | Age at years (Mean ± SD) | Age at years (Median, range) | CMR (/105) | ASMRW (/105) | YLL (years) | YLL rate (/105) |
|---|---|---|---|---|---|---|---|
| Total | 1088 (100.00) | 64.42 ± 13.22 | 63.91 (20.25-99.03) | 4.82 | 2.32 | 16372.96 | 72.46 |
| Periods | |||||||
| 2005-2008 | 200 (18.38) | 62.38 ± 13.72 | 59.01 (21.24-88.76) | 3.85 | 1.99 | 3167.79 | 60.93 |
| 2019-2012 | 255 (23.44) | 63.21 ± 13.65 | 61.52 (21.97-99.03) | 4.62 | 2.35 | 3969.98 | 71.95 |
| 2013-2016 | 302 (27.76) | 64.58 ± 12.34 | 63.93 (20.25-91.59) | 5.23 | 2.47 | 4535.75 | 78.50 |
| 2017-2020 | 331 (30.42) | 66.42 ± 13.13 | 66.20 (23.87-98.25) | 5.43 | 2.38 | 4699.43 | 77.04 |
| Underlying cause of death ovarian cancer | |||||||
| Underlying cause of death (C56) | 1067 (98.07) | 64.42 ± 13.27 | 63.85 (20.25-99.03) | 4.72 | 2.27 | 16053.68 | 71.05 |
| Underlying cause of death (C97, including C56 plus other cancers) | 21 (1.93) | 64.47 ± 10.67 | 64.46 (44.87-87.27) | 0.09 | 0.05 | 319.28 | 1.41 |
| Top three co-morbidities in all causes of ovarian cancer death | |||||||
| Diseases of the respiratory system (J00-J99) | 110 (10.11) | 66.46 ± 14.40 | 67.39 (20.25-94.02) | 0.49 | 0.22 | 1537.81 | 6.81 |
| Diseases of the digestive system (K00-K93) | 54 (4.96) | 60.43 ± 10.64 | 59.33 (33.75-83.87) | 0.24 | 0.12 | 914.61 | 4.05 |
| Diseases of the circulatory system (I00-I99) | 48 (4.41) | 65.21 ± 13.92 | 65.05 (35.88-90.35) | 0.21 | 0.10 | 706.29 | 3.13 |
| Metastatic carcinoma (C00-C96) | 336 (30.88) | 61.48 ± 12.02 | 60.73 (21.97-91.59) | 1.49 | 0.77 | 5509.36 | 24.38 |
| Metastatic ovarian cancer to the liver (C78.7) | 51 (4.69) | 60.42 ± 9.86 | 60.01 (37.52-85.54) | 0.23 | 0.12 | 862.69 | 3.82 |
| Metastatic ovarian cancer to the lung (C78.0) | 27 (2.48) | 64.13 ± 11.07 | 60.50 (37.52-84.18) | 0.12 | 0.05 | 415.80 | 1.84 |
| Metastatic ovarian cancer to the retroperitoneum and peritoneum (C78.6) | 48 (4.41) | 66.77 ± 11.17 | 64.36 (44.13-88.38) | 0.21 | 0.10 | 681.52 | 3.02 |
| Metastatic ovarian cancer to unspecified sites (C79) | 187 (17.19) | 60.36 ± 12.39 | 60.01 (21.97-91.59) | 0.83 | 0.45 | 3139.61 | 13.90 |
ASMRW, age-standardised mortality rate by Segi’s world standard population; CMR, crude mortality rate; YLL, years of life lost.